Prime Medicine, Inc. EPS (Basic, Consolidated)

EPS (Basic, Consolidated) of PRME for past 10 years: annual, quarterly and twelve month trailing (TTM) including EPS (Basic, Consolidated) growth rates and interactive chart.


Highlights and Quick Summary

  • EPS (Basic, Consolidated) for the quarter ending September 30, 2023 was -0.55 (a 17.84% increase compared to previous quarter)
  • Year-over-year quarterly EPS (Basic, Consolidated) decreased by -228.87%
  • Annual EPS (Basic, Consolidated) for 2022 was -3.59 (a -71.8% decrease from previous year)
  • Annual EPS (Basic, Consolidated) for 2021 was -12.75 (a 886.84% increase from previous year)
  • Twelve month EPS (Basic, Consolidated) ending September 30, 2023 was -1.03 (a -42.62% decrease compared to previous quarter)
  • Twelve month trailing EPS (Basic, Consolidated) decreased by -71.22% year-over-year
Trailing EPS (Basic, Consolidated) for the last four month:
30 Sep '23 30 Jun '23 31 Mar '23 31 Dec '22
-1.03 -1.8 -2.79 -3.59
Visit stockrow.com/PRME for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EPS (Basic, Consolidated) of Prime Medicine, Inc.

Most recent EPS (Basic, Consolidated)of PRME including historical data for past 10 years.

Interactive Chart of EPS (Basic, Consolidated) of Prime Medicine, Inc.

Prime Medicine, Inc. EPS (Basic, Consolidated) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 -0.55 -0.47 -0.44
2022 0.43 -1.32 -1.45 -1.25 -3.59
2021 -1.1 -12.75
2020 -1.29

Business Profile of Prime Medicine, Inc.

Sector: Healthcare
Industry: Biotechnology